CJC / IPA (No DAC)

CJC / IPA (No DAC) is a refined research blend that combines CJC-1295 without DAC—pharmacologically equivalent to Modified GRF (1-29), a GHRH-receptor agonist—with Ipamorelin, a selective ghrelin-receptor (GHS-R1a) secretagogue. Because the two peptides act on two distinct receptors and signaling axes, they are studied for their synergistic, supra-additive stimulation of growth-hormone release, while the short, no-DAC half-life is investigated for preserving a physiologically pulsatile profile. It offers researchers a precise platform for exploring growth-hormone dynamics and recovery science.